SAA2 and hepatocellular carcinoma: Since SAA is an amyloidogenic protein, by using the amyloidogenic property we further investigated the capacity of a method namely protein misfolding cyclic amplification (PMCA), with prion-like amplification of A-SAA to discriminate HCC from non-HCC groups.